Webinar: Chemo-Induced Peripheral Neuropathy: Quality of Life & Treatment Planning for Breast Cancer & Other Cancer Patients
CIPN can be an unexpected side-effect of certain breast and other cancer treatments. While the treatments save lives, the resulting CIPN can be life-changing and devastating. Our three panelists: Dr. Tom Smith (oncologist), Dr. Stefanie Geisler (neurologist), and Krista Nelson (social worker), present the latest information about the causes and treatments of CIPN, offer insight into the patient-doctor relationship, and explore the emotional challenges and medical options in coping with CIPN. The webinar concludes with a Q&A session.
This webinar was generously sponsored by Athenex Oncology and held live on Tuesday, November 10, 2020. You can find more information about CIPN from Athenex here.
Click here to watch in full screen
For a link to the slides, please click here.
From Our Blog...
Scrambler Therapy for Treating Neuropathic Pain
by Dr. Thomas Smith and Dr. Charles Loprinzi What is neuropathic pain, from the non-expert oncologist’s point of view? The way we think of it, pain
NIH Provides Two Grants for Peripheral Neuropathy Research
This past August, 2016, The National Institutes of Health (NIH) provided two separate grants supporting peripheral neuropathy research last month. This is excellent news as
Chemo-Induced Peripheral Neuropathy may be Predicted by Genetic Bio Marker
Genetic Bio Marker may Predict Chemo-Induced Peripheral Neuropathy Side Effects Associated with Prostate Cancer Treatment New study finds genetic alterations in the VAC14 gene are
Neurofeedback as alternative treatment for chemotherapy-induced peripheral neuropathy
You are unauthorized to view this page. Username Password Remember Me Forgot Password
Study Reports Peripheral Neuropathy is Associated with Mitochondrial Dysfunction
A new study led by researchers at McGill University in Canada recently revealed that peripheral neuropathy is associated with a mitochondrial dysfunction and a bioenergetic
Chemotherapy-Induced Peripheral Neuropathy Common, but Underdiagnosed
Dr. Noah Kolb, MD of the University of Utah (a consortium partner of the Foundation’s for Peripheral Neuropathy Research Registry) presented results at the recent